Mobia Medical (MOBI) Competitors

Mobia Medical logo
$13.03 +0.42 (+3.33%)
As of 04:00 PM Eastern

MOBI vs. STAA, DRTS, PRCT, TNDM, and ATEC

Should you buy Mobia Medical stock or one of its competitors? Mobia Medical's main competitors and comparable companies include STAAR Surgical (STAA), Alpha Tau Medical (DRTS), PROCEPT BioRobotics (PRCT), Tandem Diabetes Care (TNDM), and Alphatec (ATEC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Mobia Medical compare to STAAR Surgical?

Mobia Medical (NASDAQ:MOBI) and STAAR Surgical (NASDAQ:STAA) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their media sentiment, valuation, earnings, profitability, dividends, risk, analyst recommendations and institutional ownership.

Mobia Medical has higher earnings, but lower revenue than STAAR Surgical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mobia Medical$32.04M13.12-$46.50M-$20.70N/A
STAAR Surgical$239.44M5.36-$80.45MN/AN/A

In the previous week, Mobia Medical and Mobia Medical both had 3 articles in the media. STAAR Surgical's average media sentiment score of 1.03 beat Mobia Medical's score of 0.95 indicating that STAAR Surgical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mobia Medical
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
STAAR Surgical
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Mobia Medical presently has a consensus target price of $21.00, indicating a potential upside of 66.53%. STAAR Surgical has a consensus target price of $29.00, indicating a potential upside of 13.46%. Given Mobia Medical's stronger consensus rating and higher probable upside, equities research analysts plainly believe Mobia Medical is more favorable than STAAR Surgical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mobia Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
STAAR Surgical
3 Sell rating(s)
5 Hold rating(s)
4 Buy rating(s)
1 Strong Buy rating(s)
2.23

STAAR Surgical has a net margin of 0.16% compared to Mobia Medical's net margin of -135.03%. STAAR Surgical's return on equity of 8.43% beat Mobia Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Mobia Medical-135.03% -2,198.27% -52.93%
STAAR Surgical 0.16%8.43%6.50%

96.7% of STAAR Surgical shares are held by institutional investors. 39.9% of STAAR Surgical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Summary

STAAR Surgical beats Mobia Medical on 8 of the 13 factors compared between the two stocks.

How does Mobia Medical compare to Alpha Tau Medical?

Mobia Medical (NASDAQ:MOBI) and Alpha Tau Medical (NASDAQ:DRTS) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, earnings, institutional ownership, dividends, valuation, risk and media sentiment.

Mobia Medical presently has a consensus target price of $21.00, suggesting a potential upside of 66.53%. Alpha Tau Medical has a consensus target price of $18.20, suggesting a potential upside of 50.54%. Given Mobia Medical's higher possible upside, equities research analysts plainly believe Mobia Medical is more favorable than Alpha Tau Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mobia Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
Alpha Tau Medical
1 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.67

In the previous week, Alpha Tau Medical had 15 more articles in the media than Mobia Medical. MarketBeat recorded 18 mentions for Alpha Tau Medical and 3 mentions for Mobia Medical. Mobia Medical's average media sentiment score of 0.95 beat Alpha Tau Medical's score of 0.61 indicating that Mobia Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mobia Medical
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alpha Tau Medical
4 Very Positive mention(s)
2 Positive mention(s)
8 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Alpha Tau Medical has lower revenue, but higher earnings than Mobia Medical. Alpha Tau Medical is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mobia Medical$32.04M13.12-$46.50M-$20.70N/A
Alpha Tau MedicalN/AN/A-$42.63M-$1.04N/A

2.7% of Alpha Tau Medical shares are held by institutional investors. 39.5% of Alpha Tau Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Alpha Tau Medical has a net margin of 0.00% compared to Mobia Medical's net margin of -135.03%. Alpha Tau Medical's return on equity of -138.12% beat Mobia Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Mobia Medical-135.03% -2,198.27% -52.93%
Alpha Tau Medical N/A -138.12%-81.68%

Summary

Alpha Tau Medical beats Mobia Medical on 9 of the 13 factors compared between the two stocks.

How does Mobia Medical compare to PROCEPT BioRobotics?

Mobia Medical (NASDAQ:MOBI) and PROCEPT BioRobotics (NASDAQ:PRCT) are both small-cap healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, valuation, analyst recommendations, media sentiment, profitability and earnings.

89.5% of PROCEPT BioRobotics shares are held by institutional investors. 4.0% of PROCEPT BioRobotics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Mobia Medical had 2 more articles in the media than PROCEPT BioRobotics. MarketBeat recorded 3 mentions for Mobia Medical and 1 mentions for PROCEPT BioRobotics. Mobia Medical's average media sentiment score of 0.95 beat PROCEPT BioRobotics' score of 0.91 indicating that Mobia Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mobia Medical
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
PROCEPT BioRobotics
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Mobia Medical presently has a consensus target price of $21.00, indicating a potential upside of 66.53%. PROCEPT BioRobotics has a consensus target price of $25.25, indicating a potential upside of 6.18%. Given Mobia Medical's stronger consensus rating and higher possible upside, research analysts clearly believe Mobia Medical is more favorable than PROCEPT BioRobotics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mobia Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
PROCEPT BioRobotics
2 Sell rating(s)
9 Hold rating(s)
2 Buy rating(s)
3 Strong Buy rating(s)
2.38

PROCEPT BioRobotics has a net margin of -32.60% compared to Mobia Medical's net margin of -135.03%. PROCEPT BioRobotics' return on equity of -33.23% beat Mobia Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Mobia Medical-135.03% -2,198.27% -52.93%
PROCEPT BioRobotics -32.60%-33.23%-23.58%

Mobia Medical has higher earnings, but lower revenue than PROCEPT BioRobotics. PROCEPT BioRobotics is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mobia Medical$32.04M13.12-$46.50M-$20.70N/A
PROCEPT BioRobotics$308.05M4.44-$95.57M-$2.02N/A

Summary

PROCEPT BioRobotics beats Mobia Medical on 8 of the 15 factors compared between the two stocks.

How does Mobia Medical compare to Tandem Diabetes Care?

Tandem Diabetes Care (NASDAQ:TNDM) and Mobia Medical (NASDAQ:MOBI) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

In the previous week, Tandem Diabetes Care had 17 more articles in the media than Mobia Medical. MarketBeat recorded 20 mentions for Tandem Diabetes Care and 3 mentions for Mobia Medical. Tandem Diabetes Care's average media sentiment score of 1.00 beat Mobia Medical's score of 0.95 indicating that Tandem Diabetes Care is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Tandem Diabetes Care
10 Very Positive mention(s)
7 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Mobia Medical
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Tandem Diabetes Care has a net margin of -4.58% compared to Mobia Medical's net margin of -135.03%. Tandem Diabetes Care's return on equity of -35.61% beat Mobia Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Tandem Diabetes Care-4.58% -35.61% -4.53%
Mobia Medical -135.03%-2,198.27%-52.93%

Tandem Diabetes Care presently has a consensus price target of $27.18, suggesting a potential upside of 59.34%. Mobia Medical has a consensus price target of $21.00, suggesting a potential upside of 66.53%. Given Mobia Medical's stronger consensus rating and higher probable upside, analysts clearly believe Mobia Medical is more favorable than Tandem Diabetes Care.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Tandem Diabetes Care
1 Sell rating(s)
12 Hold rating(s)
9 Buy rating(s)
1 Strong Buy rating(s)
2.43
Mobia Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57

Mobia Medical has lower revenue, but higher earnings than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tandem Diabetes Care$1.01B1.17-$204.71M-$0.72N/A
Mobia Medical$32.04M13.12-$46.50M-$20.70N/A

Summary

Tandem Diabetes Care beats Mobia Medical on 9 of the 13 factors compared between the two stocks.

How does Mobia Medical compare to Alphatec?

Mobia Medical (NASDAQ:MOBI) and Alphatec (NASDAQ:ATEC) are both small-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Mobia Medical has higher earnings, but lower revenue than Alphatec. Alphatec is trading at a lower price-to-earnings ratio than Mobia Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Mobia Medical$32.04M13.12-$46.50M-$20.70N/A
Alphatec$764.16M1.41-$143.36M-$0.55N/A

In the previous week, Alphatec had 11 more articles in the media than Mobia Medical. MarketBeat recorded 14 mentions for Alphatec and 3 mentions for Mobia Medical. Mobia Medical's average media sentiment score of 0.95 beat Alphatec's score of -0.21 indicating that Mobia Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Mobia Medical
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Alphatec
1 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Neutral

66.4% of Alphatec shares are owned by institutional investors. 13.5% of Alphatec shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Alphatec has a net margin of -10.35% compared to Mobia Medical's net margin of -135.03%. Mobia Medical's return on equity of -2,198.27% beat Alphatec's return on equity.

Company Net Margins Return on Equity Return on Assets
Mobia Medical-135.03% -2,198.27% -52.93%
Alphatec -10.35%-6,752.24%-9.77%

Mobia Medical currently has a consensus target price of $21.00, suggesting a potential upside of 66.53%. Alphatec has a consensus target price of $15.37, suggesting a potential upside of 121.42%. Given Alphatec's stronger consensus rating and higher possible upside, analysts plainly believe Alphatec is more favorable than Mobia Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Mobia Medical
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.57
Alphatec
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71

Summary

Alphatec beats Mobia Medical on 10 of the 14 factors compared between the two stocks.

Get Mobia Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for MOBI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MOBI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MOBI vs. The Competition

MetricMobia MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$434.26M$5.92B$7.60B$11.72B
Dividend YieldN/A1.68%2.47%4.48%
P/E Ratio-0.6338.8433.5830.13
Price / Sales8.375.688.255.59
Price / CashN/A23.6221.0121.90
Price / Book2.754.214.443.72
Net Income-$46.50M$143.14M$3.50B$393.88M
7 Day Performance-3.27%-5.62%-6.53%-6.07%
1 Month Performance61.06%-3.77%-4.93%-7.38%
1 Year PerformanceN/A-0.16%-1.73%-7.48%

Mobia Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MOBI
Mobia Medical
3.2493 of 5 stars
$13.03
+3.3%
$21.00
+61.2%
N/A$434.26M$51.89MN/A167
STAA
STAAR Surgical
2.7134 of 5 stars
$25.21
-5.7%
$29.00
+15.0%
-3.5%$1.26B$239.44MN/A957
DRTS
Alpha Tau Medical
3.2104 of 5 stars
$13.72
+3.2%
$15.40
+12.2%
+217.3%$1.24BN/AN/A121
PRCT
PROCEPT BioRobotics
1.2789 of 5 stars
$20.62
+1.7%
$25.25
+22.5%
-18.2%$1.19B$308.05MN/A888
TNDM
Tandem Diabetes Care
3.2292 of 5 stars
$16.91
-6.0%
$27.18
+60.8%
-7.0%$1.18B$1.01BN/A2,500

Related Companies and Tools


This page (NASDAQ:MOBI) was last updated on 11/18/2026 by MarketBeat.com Staff.
From Our Partners